Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan

March 14, 2025 9:25 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, today provided an update on its financing plans. The Company announced that it has engaged J.P. Morgan in connection with the Company's previously announced financing objectives.Any transactions would be subject to market and other conditions and there can be no assurance...

Read more

NV Behavioral Health Services Rebrands as Therapize Me: Empowering Mental Health for All

March 14, 2025 9:00 AM

NV Behavioral Health Services is proud to announce its rebranding to Therapize Me, marking a new chapter in our commitment to mental health and wellness. The new name reflects a mission to create a supportive environment where individuals can openly discuss their mental health and access the care they need.At Therapize Me, mental health is recognized as a crucial foundation for a successful and fulfilled lifestyle. Striving to dismantle the...

Read more

Senzime Secures Additional US Hospital System Contracts

March 14, 2025 8:10 AM

Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured new important US hospital system contracts including initial delivery of 60 next-generation TetraGraph neuromuscular monitoring systems to an Integrated Delivery Network (IDN) with strong presence in the Northeastern region."This demonstrates the power of our solutions and the capabilities we have in meeting demands of large US hospital systems. The new IDN contract was...

Read more

Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease

March 14, 2025 7:45 AM

Gain Therapeutics, Inc. (Nasdaq:GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced the dosing of the first participant with Parkinson's disease (PD) in its Phase 1b clinical trial of GT-02287, the Company's lead allosteric small molecule in development for the treatment of PD with or without a GBA1 mutation. ...

Read more

Nemysis Limited Announces Collaboration With Avia Pharma AB as IHAT Distributor in Nordic Region

March 14, 2025 5:30 AM

Nemysis is pleased to announce signing of a Distribution and Supply Agreement (the "Agreement") for its unique oral iron supplement, Iron Hydroxide Adipate Tartrate ("IHAT"), with Avia Pharma AB ("Avia"), which will act as distributor.Under the Agreement, Avia is appointed as the exclusive partner to Nemysis for the promotion, marketing, distribution and sale of Nemysis' proprietary IHAT product under the Tolfer brand, under license.Avia's...

Read more

Mompreneurs and Addison Care Crack the Code for U.S. Caregiving

March 13, 2025 4:30 PM

Electronic Caregiver, the leading provider of innovative health technology solutions, has launched a nationwide direct sales initiative aimed at empowering female entrepreneurs. This initiative offers a lucrative, meaningful, and home-based business opportunity centered around Addison Care, the company's groundbreaking Virtual Health Companion. With live caregiving costs financially out of reach for most Americans, Addison Care provides an...

Read more

Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth

March 13, 2025 4:28 PM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the fourth quarter and year-ended December 31, 2024."We wrapped up a strong 2024 with solid performance in the fourth quarter as we posted record revenue, year over year, for the 15th straight quarter," said Larry...

Read more

Jaguar Health Reports Approval of All Proposals at March 2025 Special Meeting of Stockholders

March 13, 2025 4:15 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the Company's Special Meeting of Stockholders held on March 13, 2025 (the "Special Meeting").Two proposals were submitted to and approved by the stockholders of the Company at the Special Meeting. The proposals are described in detail in the Company's definitive proxy statement on Schedule 14A relating to the Special Meeting and supplemental...

Read more

Patients for Patient Safety US Tackles #1 Patient Safety Challenge Facing the Health Care Industry: Dismissing Patient and Family Concerns

March 13, 2025 4:00 PM

Patients for Patient Safety US (PFPS US) forges ahead with Project PIVOT, capturing outcomes and experiences that matter most to patients who have experienced the dismissal of patient and family concerns that resulted in harm or a near miss. The patient input from Project PIVOT will inform the development of patient-reported measures used in quality assessment as well as measures used in patient-centered research and quality improvements,...

Read more

Women in 33 States Now Benefit from Safe Seated Mammography and Better Imaging with the VELA Mammography Chair, Enable Me Finds

March 13, 2025 2:30 PM

Tampa-based Enable Me, a VELA Medical company, announced today that in just over two years, hospitals and clinics in 33 states have embraced the clinically designed, high tech, FDA approved VELA Mammography Chair for its many benefits for patients and mammography technologists and its value to clinic workflow and safer operations. "Because we truly believe that women deserve the highest quality healthcare available, our goal is to have safe...

Read more

Centre For Neuro Skills to Open Clinic in Plano; Fifth in Texas

March 13, 2025 11:45 AM

Centre for Neuro Skills (CNS), a premier provider of treatment for traumatic and acquired brain injury, today announced the opening of its new clinic in Plano, Texas. CNS' approximately 20,000 square ft. facility at 1649 Dallas Parkway will open to new patients in winter 2025-2026."Over the past few years, we've seen population growth in the North Dallas area, with Plano being one of the fastest growing regions," said David Harrington, CEO of...

Read more

Travel Nurses, Inc. Announces First Quarter Daisy Award Honoree

March 13, 2025 10:00 AM

Travel Nurses, Inc. announced their first quarter DAISY Award recipient for 2025. Becky Walker, RN from Carrollton, Mississippi was presented with this prestigious award during a ceremony with her travel partner and the Travel Nurses, Inc. staff.The DAISY Award is a prestigious international program that honors nurses for their exceptional clinical expertise and compassionate care. DAISY, which stands for "Diseases Attacking the Immune System,"...

Read more

Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose’s Potential in Chip Manufacturing and More

March 13, 2025 9:00 AM

Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced that Water Tower Research ("WTR") has published a report spotlighting Ainos' strategic collaboration with Advanced Semiconductor Engineering, Inc. ("ASE"), the world's largest provider of semiconductor packaging and testing services. The partnership will integrate Ainos' AI Nose, an AI-powered electric nose technology, into...

Read more

Intiva Health Expands Into a Multi-Industry Powerhouse, Uniting Incredable, Nova Vita, and Gummi World

March 13, 2025 9:00 AM

Intiva Health proudly announces its transformation into a dynamic parent company overseeing three industry-leading brands: Incredable, Nova Vita, and Gummi World. This strategic evolution solidifies Intiva Health's committment to driving innovation, efficiency, and well-being across healthcare, wellness, and nutraceutical sectors.As these industries continue to evolve rapidly, Intiva Health is at the forefront, pioneering advancements that...

Read more

Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform

March 13, 2025 8:30 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today provided an update on its two patent applications, originally filed as provisional patent applications with the U.S. Patent and Trademark Office ("USPTO") on March 31, 2023 and October 2, 2024, respectively, pertaining to Oral Mucosal Formulations of Aspirin that utilize Aspire's fast acting...

Read more

MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain

March 13, 2025 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain. This advancement expands the Company's pain management portfolio beyond its ongoing Ketamir-2 oral treatment for neuropathic pain, offering a novel,...

Read more

Dr. Alexander Donath Honored as a 2025 Top Doctor by Castle Connolly

March 13, 2025 8:00 AM

Dr. Alexander Donath, an internationally renowned facial plastic surgeon, has been recognized as a 2025 Castle Connolly Top Doctor, marking his 14th consecutive year receiving this prestigious distinction. This recognition reflects his commitment to patient care, surgical expertise, and contributions to the field of facial plastic surgery. Dr. Donath's selection places him among the top 7% of physicians nationwide, a distinction determined...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Announces Installation of Both FORME and CLMBR at Mandalay Bay Resort

March 13, 2025 7:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that both its FORME and CLMBR equipment were installed at the Mandalay Bay Resort, one of the most frequently visited fitness facilities in the US, and coinciding with the start of the 2025 Health & Fitness Association Show that is being hosted at the Mandalay Bay Convention...

Read more

Cantargia to Participate at Van Lanschot Kempen’s Life Sciences Conference

March 13, 2025 5:20 AM

Cantargia (STO:CANTA) Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm: CANTA) today announced that members of Cantargia's management will participate at the Van Lanschot Kempen Life Sciences Conference in Amsterdam on Thursday, April 3, 2025.One-on-one and group meetingsThursday, April 3, 2025.For further information, please contactDamian Marron, Interim CEOTelephone: +46 (0)46-275 62 60E-mail: [email protected]...

Read more

CORRECTION: Monogram Technologies Reports Full Year 2024 Financial Results

March 12, 2025 7:15 PM

Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, has reported its financial and operational results for the fourth quarter and year ended December 31, 2024.Fourth Quarter 2024 and Subsequent Operational HighlightsCompleted all supplemental testing and submitted its formal response to the U.S. Food and Drug...

Read more